This focused narrative review synthesizes direct and adjacent literature on the intersection between diabetes and suicide risk, with particular attention to Black males and Black sexual minority males (SMM). The authors note that diabetes and suicide are both major public health concerns, yet studies that directly examine their overlap in Black male populations are sparse. The review aims to identify clinically relevant pathways, highlight structural and intersectional contributors, and articulate implications for primary care clinicians.
Across heterogeneous studies, several recurrent clinical pathways emerge linking diabetes to suicidal thoughts and behaviors. These include comorbid depression, diabetes distress, the burden of treatment and self-management, complications related to diabetes, and difficulties accessing essential medications including insulin. The review emphasizes these pathways as proximal mechanisms supported in the broader diabetes–suicide literature rather than conclusive causal evidence for specific subpopulations.
Depression is commonly observed in people living with diabetes and is a well-established risk factor for suicidal ideation and attempts. Diabetes-specific distress—emotional strain directly tied to disease management demands—also appears important. Treatment burden and complications can exacerbate psychological distress and reduce quality of life, which in turn may increase suicide risk. Medication access issues, such as constrained access to insulin or other therapies, are identified as clinically relevant stressors that may contribute to risk in people with diabetes.
The review highlights several higher-level contributors that may amplify the clinical mechanisms listed above for Black males. Structural racism, economic inequity, discrimination within health care settings, and constrained access to high-quality diabetes and mental health services are described as potential intensifiers of the psychosocial burden associated with diabetes. Intersectional stress processes—where race, gender, sexual orientation, and socioeconomic position co-occur—are underscored as critical contexts shaping risk, though the evidence base examining these intersectional effects remains limited.
Direct evidence focused on Black males with diabetes is limited. The review reports one directly relevant study that found higher lifetime suicide attempts among African American adults with type 1 diabetes compared with controls; however, that study did not provide estimates disaggregated by sex, so male-specific prevalence or risk could not be determined from that result.
For Black sexual minority males (SMM), the authors identified no studies that specifically estimate diabetes-related suicidal thoughts or behaviors. This absence of subgroup-specific data is framed by the authors as a central evidence gap: the literature does not currently provide population-specific estimates for Black SMM, nor does it establish whether risk is multiplicatively increased when diabetes intersects with racial, gender, and sexual-minority stressors.
Commonly used clinical measures appear throughout the reviewed literature. The Patient Health Questionnaire-9 (PHQ‑9) for depressive symptoms, the Diabetes Distress Scale for diabetes-specific emotional distress, and the Columbia-Suicide Severity Rating Scale (C-SSRS) for suicidal thoughts and behaviors are identified as tools with broad clinical support.
Crucially, the review finds that the literature it surveyed did not establish the population-specific validity of these instruments for Black males with diabetes or for Black SMM. The authors caution clinicians against assuming that screening tools perform equivalently across diverse populations and note the need for validation studies that specifically examine psychometric properties and clinical utility in these groups.
Given the current state of evidence, the review sets out practical guidance for primary care clinicians caring for Black males with diabetes, including those who are sexual minority males. Recommended actions include:
Employ culturally responsive psychosocial inquiry that recognizes structural and intersectional contributors to distress.
Conduct direct suicide assessment when indicated by clinical presentation or risk factors rather than relying solely on screening tools.
Use collaborative safety planning with patients identified at elevated risk, incorporating accessible means reduction and contingency planning tailored to individual circumstances.
Integrate behavioral health services within primary care or ensure expedited referral pathways to mental health care to address depression and diabetes distress.
Avoid assuming screening measures have equal validity across populations; interpret results in context and consider follow-up assessment or specialist consultation when needed.
These clinical recommendations are presented as prudent practice informed by the literature’s identified mechanisms and gaps rather than as evidence-based protocols proven in Black male or Black SMM populations specifically.
The authors emphasize that the central finding of the review is an evidence gap. Key research priorities they articulate include prospective, disaggregated epidemiologic studies that estimate diabetes-related suicidal ideation and attempts specifically among Black males and Black SMM. They also call for measurement research to validate commonly used instruments (PHQ‑9, Diabetes Distress Scale, C-SSRS) within these populations to ensure accurate detection and monitoring.
Until such evidence is available, clinicians are advised to practice enhanced vigilance and culturally informed assessment, to use integrated behavioral health approaches where possible, and to participate in or advocate for research that disaggregates data by race, sex, and sexual orientation. The review stops short of asserting a multiplicative risk effect in these subgroups, noting that absence of evidence is not evidence of absence; rather, the literature currently cannot determine whether risk differs in magnitude for Black males, including Black SMM.
This narrative review synthesizes available literature at the intersection of diabetes and suicide, identifies plausible clinical pathways and structural amplifiers relevant to Black males and Black sexual minority males, and issues practical primary care recommendations in the context of marked evidence gaps. The authors call for prospective and disaggregated research and for population-specific validation of screening and assessment tools to guide equitable clinical practice.